FULCRUM Trademark

Trademark Overview

On Tuesday, May 14, 2019, a trademark application was filed for FULCRUM with the United States Patent and Trademark Office. The USPTO has given the FULCRUM trademark a serial number of 88430181. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Fulcrum Therapeutics, Inc.. The FULCRUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of neuromuscular, hematological, rare and genetically defined diseases and disorders
fulcrum

General Information

Serial Number88430181
Word MarkFULCRUM
Filing DateTuesday, May 14, 2019
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7012695
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of neuromuscular, hematological, rare and genetically defined diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2019
Primary Code005
First Use Anywhere DateMonday, August 19, 2019
First Use In Commerce DateMonday, August 19, 2019

Trademark Owner History

Party NameFulcrum Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameFulcrum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameFulcrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, February 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, February 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 10, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 2023USE AMENDMENT FILED
Friday, January 13, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 5 GRANTED
Thursday, July 14, 2022SOU EXTENSION 5 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 7, 2022SOU EXTENSION 4 GRANTED
Friday, January 7, 2022SOU EXTENSION 4 FILED
Friday, January 7, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 11, 2021CORRECTED NOA E-MAILED
Tuesday, May 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2021DIVISIONAL PROCESSING COMPLETE
Monday, April 19, 2021DIVISIONAL REQUEST RECEIVED
Monday, May 10, 2021SOU EXTENSION 3 GRANTED
Monday, April 19, 2021SOU EXTENSION 3 FILED
Monday, May 10, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 19, 2021TEAS REQUEST TO DIVIDE RECEIVED
Monday, April 19, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 30, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 30, 2020SOU EXTENSION 2 FILED
Wednesday, December 30, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2020SOU EXTENSION 1 GRANTED
Friday, June 5, 2020SOU EXTENSION 1 FILED
Friday, June 5, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2019ASSIGNED TO LIE
Thursday, October 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2019NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2019ASSIGNED TO EXAMINER
Thursday, May 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 17, 2019NEW APPLICATION ENTERED

Related Keywords

fulcrum defined diseases disorders genetically rare treatment neuromuscular hematological pharmaceuticals